Levie K - Search Results

1

An adjuvanted, low-dose, pandemic influenza A (H5N1) vaccine candidate is safe, immunogenic, and induces cross-reactive immune responses in healthy adults.

Levie K, Leroux-Roels I, Hoppenbrouwers K, Kervyn AD, Vandermeulen C, Forgus S, Leroux-Roels G, Pichon S, Kusters I. Levie K, et al. J Infect Dis. 2008 Sep 1;198(5):642-9. doi: 10.1086/590913. J Infect Dis. 2008. PMID: 18576945 Clinical Trial.

2

Immunogenicity and safety of three doses of a bivalent (B:4:p1.19,15 and B:4:p1.7-2,4) meningococcal outer membrane vesicle vaccine in healthy adolescents.

Boutriau D, Poolman J, Borrow R, Findlow J, Domingo JD, Puig-Barbera J, Baldó JM, Planelles V, Jubert A, Colomer J, Gil A, Levie K, Kervyn AD, Weynants V, Dominguez F, Barberá R, Sotolongo F. Boutriau D, et al. Among authors: levie k. Clin Vaccine Immunol. 2007 Jan;14(1):65-73. doi: 10.1128/CVI.00230-06. Epub 2006 Oct 25. Clin Vaccine Immunol. 2007. PMID: 17065257 Free PMC article. Clinical Trial.

3

A 2-dose regimen of a recombinant hepatitis B vaccine with the immune stimulant AS04 compared with the standard 3-dose regimen of Engerix-B in healthy young adults.

Levie K, Gjorup I, Skinhøj P, Stoffel M. Levie K, et al. Scand J Infect Dis. 2002;34(8):610-4. doi: 10.1080/00365540110080881. Scand J Infect Dis. 2002. PMID: 12238579 Clinical Trial.

4

Long term (24 months) follow-up of a hepatitis A and B vaccine, comparing a two and three dose schedule in adolescents aged 12-15 years.

Levie K, Beran J, Collard F, Nguyen C. Levie K, et al. Vaccine. 2002 Jun 7;20(19-20):2579-84. doi: 10.1016/s0264-410x(02)00153-6. Vaccine. 2002. PMID: 12057615 Clinical Trial.

5

Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11-15 years: a randomised controlled trial.

Heron L, Selnikova O, Moiseieva A, Van Damme P, van der Wielen M, Levie K, Hoet B, Stoffel M. Heron L, et al. Among authors: levie k. Vaccine. 2007 Apr 12;25(15):2817-22. doi: 10.1016/j.vaccine.2006.12.021. Epub 2006 Dec 29. Vaccine. 2007. PMID: 17276552 Clinical Trial.

6

A single dose, combined vaccine against typhoid fever and hepatitis A: consistency, immunogenicity and reactogenicity.

Beran J, Beutels M, Levie K, Van Damme P, Dieussaert I, Gillet M, Van Hoecke C, Tornieporth N. Beran J, et al. Among authors: levie k. J Travel Med. 2000 Sep-Oct;7(5):246-52. doi: 10.2310/7060.2000.00073. J Travel Med. 2000. PMID: 11231208 Free article. Clinical Trial.

7

Quality Assurance and Technology-Enabled Curation of Oncology Real-World Data: The Importance of Individual Quality Reviews.

Levie K, Cromartie B, Wicks M, Burkhart J, Kennedy S, Hess D, Wolf F, Widmer L. Levie K, et al. J Registry Manag. 2023 Summer;50(2):60-63. J Registry Manag. 2023. PMID: 37575551 Free PMC article.

8

Prospective quality of life in men choosing open vs. robotic radical prostatectomy: long-term results from a racially diverse multi-institutional database.

Kord E, Jung N, Boehm B, Conti G, Kuo HC, Frankel J, Flores J, Levie K, Ho O, Elsamanoudi S, Jiang J, Stroup SP, Musser J, Ernest A, Speir R, Chesnut G, Tausch TJ, Porter C. Kord E, et al. Among authors: levie k. World J Urol. 2022 Jun;40(6):1427-1436. doi: 10.1007/s00345-022-03975-8. Epub 2022 Mar 12. World J Urol. 2022. PMID: 35279731

9

A prospective analysis of health-related quality of life in intermediate and high-risk prostate cancer patients managed with intensity modulated radiation therapy, with vs. without hormonal therapy.

Caumont F, Conti G, Hurwitz LM, Kuo C, Levie KE, Badiozamani K, Frankel JK, Flores JP, Brand TC, Chaurasia A, Rosner IL, Stroup SP, Musser JE, Cullen J, Porter CR. Caumont F, et al. Among authors: levie ke. Urol Oncol. 2020 Oct;38(10):794.e1-794.e9. doi: 10.1016/j.urolonc.2020.02.007. Epub 2020 Mar 3. Urol Oncol. 2020. PMID: 32139288

10

A prospective study of health-related quality of life outcomes among men treated for intermediate- and high-risk prostate cancer: the impact of primary and secondary therapies.

Alsinnawi M, Cullen J, Hurwitz LM, Levie KE, Burns JF, Rosner IL, Brand TC, Stroup S, Sterbis JR, Rice K, Conti G, Porter CR. Alsinnawi M, et al. Among authors: levie ke. Can J Urol. 2019 Aug;26(4):9809-9820. Can J Urol. 2019. PMID: 31469635

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page